Cargando…

Helicobacter pylori Induces IL-33 Production and Recruits ST-2 to Lipid Rafts to Exacerbate Inflammation

Helicobacter pylori colonizes human gastric epithelial cells and contributes to the development of several gastrointestinal disorders. Interleukin (IL)-33 is involved in various immune responses, with reported proinflammatory and anti-inflammatory effects, which may be associated with colitis and co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuo, Chia-Jung, Chen, Chun-Ya, Lo, Horng-Ren, Feng, Chun-Lung, Wu, Hui-Yu, Huang, Mei-Zi, Liao, Tung-Nan, Chen, Yu-An, Lai, Chih-Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830106/ https://www.ncbi.nlm.nih.gov/pubmed/31640262 http://dx.doi.org/10.3390/cells8101290

Ejemplares similares

Helicobacter pylori Activates HMGB1 Expression and Recruits RAGE into Lipid Rafts to Promote Inflammation in Gastric Epithelial Cells
por: Lin, Hwai-Jeng, et al.
Publicado: (2016)

Campylobacter jejuni Cytolethal Distending Toxin C Exploits Lipid Rafts to Mitigate Helicobacter pylori-Induced Pathogenesis
por: Yeh, Jia-Yin, et al.
Publicado: (2021)

Role of lipid rafts in persistent Helicobacter pylori infection: a narrative review
por: Liu, Renjie, et al.
Publicado: (2022)

Emerging Roles of IL-33/ST2 Axis in Renal Diseases
por: Chen, Wei-Yu, et al.
Publicado: (2017)

Effects of Helicobacter pylori infection in gastrointestinal tract malignant diseases: From the oral cavity to rectum
por: Kuo, Yang-Che, et al.
Publicado: (2022)

Statin Decreases Helicobacter pylori Burden in Macrophages by Promoting Autophagy
por: Liao, Wei-Chih, et al.
Publicado: (2017)

Helicobacter pylori-induced IL-33 modulates mast cell responses, benefits bacterial growth, and contributes to gastritis
por: Lv, Yi-pin, et al.
Publicado: (2018)

Coalescence of RAGE in Lipid Rafts in Response to Cytolethal Distending Toxin-Induced Inflammation
por: Lin, Hwai-Jeng, et al.
Publicado: (2019)

Proregenerative Activity of IL-33 in Gastric Tissue Cells Undergoing Helicobacter Pylori-Induced Apoptosis
por: Gonciarz, Weronika, et al.
Publicado: (2020)

IL‐33/ST2 axis deficiency exacerbates neutrophil‐dominant allergic airway inflammation
por: Ma, Qiyun, et al.
Publicado: (2021)

IL-33/ST2 axis mediates hyperplasia of intrarenal urothelium in obstructive renal injury
por: Chen, Wei-Yu, et al.
Publicado: (2018)

Measurement of Interleukin-33 (IL-33) and IL-33 Receptors (sST2 and ST2L) in Patients with Rheumatoid Arthritis
por: Hong, Yeon-Sik, et al.
Publicado: (2011)

Helicobacter pylori infection and increased diabetes prevalence were the risks of colorectal adenoma for adults: A systematic review and meta-analysis (PRISMA-compliant article)
por: Ko, Hung-Ju, et al.
Publicado: (2021)

Aggravation of Helicobacter pylori stomach infections in stressed military recruits
por: Jia, Keran, et al.
Publicado: (2016)

Evaluation of Anti-Helicobacter pylori IgG Antibodies for the Detection of Helicobacter pylori Infection in Different Populations
por: Yu, Jin-Han, et al.
Publicado: (2022)

Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori
por: Ra, Seung Won, et al.
Publicado: (2017)

Efficacy of dexlansoprazole-based triple therapy for Helicobacter pylori infections
por: Kuo, Chia-Jung, et al.
Publicado: (2019)

Factors Affecting the Intraluminal Therapy for Helicobacter pylori Infection
por: Ho, Cheng-Yu, et al.
Publicado: (2022)

An Evidence-Based Approach to the Management of Functional Dyspepsia Associated With Helicobacter pylori Infection
por: Lee, Shou-Wu, et al.
Publicado: (2014)

Helicobacter pylori and Systemic Disease
por: Kuo, Chao-Hung, et al.
Publicado: (2014)

Probiotic Lactobacillus spp. Act Against Helicobacter pylori-induced Inflammation
por: Chen, Yi-Hsing, et al.
Publicado: (2019)

Antagonistic Activities of Lactobacillus rhamnosus JB3 Against Helicobacter pylori Infection Through Lipid Raft Formation
por: Do, Anh Duy, et al.
Publicado: (2022)

Preparation of epigallocatechin gallate-loaded nanoparticles and characterization of their inhibitory effects on Helicobacter pylori growth in vitro and in vivo
por: Lin, Yu-Hsin, et al.
Publicado: (2014)

Statins’ Regulation of the Virulence Factors of Helicobacter pylori and the Production of ROS May Inhibit the Development of Gastric Cancer
por: Lin, Ting-Yu, et al.
Publicado: (2021)

Helicobacter pylori infection combined with non-alcoholic fatty liver disease increase the risk of atherosclerosis: Focus in carotid artery plaque
por: Yu, Lo-Yip, et al.
Publicado: (2019)

High yield purification of Helicobacter pylori neutrophil-activating protein overexpressed in Escherichia coli
por: Yang, Yu-Chi, et al.
Publicado: (2015)

The Effect of Helicobacter pylori Eradication on the Levels of Essential Trace Elements
por: Wu, Meng-Chieh, et al.
Publicado: (2014)

IL-22 Negatively Regulates Helicobacter pylori-Induced CCL20 Expression in Gastric Epithelial Cells
por: Chen, Jia-Perng, et al.
Publicado: (2014)

The ST2/Interleukin-33 Axis in Hematologic Malignancies: The IL-33 Paradox
por: Allegra, Alessandro, et al.
Publicado: (2019)

Hyperglycemia combined Helicobacter pylori infection increases risk of synchronous colorectal adenoma and carotid artery plaque
por: Hu, Kuang-Chun, et al.
Publicado: (2017)

Helicobacter pylori metabolites exacerbate gastritis through C-type lectin receptors
por: Nagata, Masahiro, et al.
Publicado: (2020)

ST2 and IL-33 in Pregnancy and Pre-Eclampsia
por: Granne, Ingrid, et al.
Publicado: (2011)

Role of the IL-33-ST2 axis in sepsis
por: Xu, Hui, et al.
Publicado: (2017)

IL-33/ST2 Axis in Organ Fibrosis
por: Kotsiou, Ourania S., et al.
Publicado: (2018)

The Role of IL-33/ST2 Pathway in Tumorigenesis
por: Larsen, Kristen M., et al.
Publicado: (2018)

The IL-33/ST2 Pathway in Cerebral Malaria
por: Glineur, Corine, et al.
Publicado: (2022)

Toward population specific and personalized treatment of Helicobacter pylori infection
por: Liou, Jyh-Ming, et al.
Publicado: (2018)

First-Line Helicobacter pylori Eradication in Patients with Chronic Kidney Diseases in Taiwan
por: Liang, Chih-Ming, et al.
Publicado: (2017)

Mutant selection window of clarithromycin for clinical isolates of Helicobacter pylori
por: Feng, Zi-Han, et al.
Publicado: (2019)

The Impact of Gastric Juice pH on the Intraluminal Therapy for Helicobacter pylori Infection
por: Wang, Yu-Chio, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d7i19b0h7cq5mubtfqdsnlr0lc